These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26479566)

  • 1. Return of Results from Research Using Newborn Screening Dried Blood Samples.
    Lewis MH; Goldenberg AJ
    J Law Med Ethics; 2015; 43(3):559-68. PubMed ID: 26479566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental Consent for the Use of Residual Newborn Screening Bloodspots: Respecting Individual Liberty vs Ensuring Public Health.
    Bayefsky MJ; Saylor KW; Berkman BE
    JAMA; 2015 Jul; 314(1):21-2. PubMed ID: 26053685
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative analysis of the governance and use of residual dried blood spots from state newborn screening programs and neonatal biobanks.
    Preslan ED; Mathews DJ
    J Empir Res Hum Res Ethics; 2013 Jul; 8(3):22-33. PubMed ID: 23933773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual newborn screening samples for research: parental information needs for decision-making.
    Rothwell E; Clark L; Anderson R; Botkin JR
    J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State laws regarding the retention and use of residual newborn screening blood samples.
    Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
    Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylome profiling using neonatal dried blood spot samples: a proof-of-principle study.
    Hollegaard MV; Grauholm J; Nørgaard-Pedersen B; Hougaard DM
    Mol Genet Metab; 2013 Apr; 108(4):225-31. PubMed ID: 23422032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of archived dried blood spot samples from the Danish Neonatal Screening Biobank.
    Grauholm J; Khoo SK; Nickolov RZ; Poulsen JB; Bækvad-Hansen M; Hansen CS; Hougaard DM; Hollegaard MV
    Mol Genet Metab; 2015 Nov; 116(3):119-24. PubMed ID: 26212339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Storage and use of residual dried blood spots from state newborn screening programs.
    Olney RS; Moore CA; Ojodu JA; Lindegren ML; Hannon WH
    J Pediatr; 2006 May; 148(5):618-22. PubMed ID: 16737872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn bloodspot retention reinstated in Minnesota: practice expected to benefit larger newborn screening studies, public health, disease research.
    Am J Med Genet A; 2014 Sep; 164A(9):viii-ix. PubMed ID: 25125344
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethical issues with newborn screening in the genomics era.
    Tarini BA; Goldenberg AJ
    Annu Rev Genomics Hum Genet; 2012; 13():381-93. PubMed ID: 22559326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
    Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
    Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Michigan BioTrust for Health: using dried bloodspots for research to benefit the community while respecting the individual.
    Chrysler D; McGee H; Bach J; Goldman E; Jacobson PD
    J Law Med Ethics; 2011 Mar; 39 Suppl 1():98-101. PubMed ID: 21309908
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical, legal and social issues in newborn screening in the United States.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():52-8. PubMed ID: 15906695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of neonatal dried blood spot retrieval amid evolving state policies (2009-2010): a Children's Oncology Group study.
    Linabery AM; Slater ME; Spector LG; Olshan AF; Stork SK; Roesler MA; Reaman GH; Ross JA
    Paediatr Perinat Epidemiol; 2011 Nov; 25(6):549-58. PubMed ID: 21980944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mass spectrometry to analyze dried blood spots.
    Wagner M; Tonoli D; Varesio E; Hopfgartner G
    Mass Spectrom Rev; 2016; 35(3):361-438. PubMed ID: 25252132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dried blood spot sampling method in the laboratory medicine.
    Andrlova L; Kandar R
    Bratisl Lek Listy; 2019; 120(3):223-234. PubMed ID: 31023042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois.
    Hart A; Petros M; Charrow J; Nash C; Wicklund C
    J Genet Couns; 2015 Jun; 24(3):482-90. PubMed ID: 25410141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention and research use of residual newborn screening bloodspots.
    Botkin JR; Goldenberg AJ; Rothwell E; Anderson RA; Lewis MH
    Pediatrics; 2013 Jan; 131(1):120-7. PubMed ID: 23209103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn Screening Samples for Diabetes Research: An Underused Resource.
    Estrella JFGL; Immanuel J; Wiley V; Simmons D
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.